• Publications
  • Influence
Macrophage colony stimulating factor: not just for macrophages anymore! A gateway into complex biologies.
Macrophage colony stimulating factor (M-CSF, also called colony stimulating factor-1) has traditionally been viewed as a growth/differentiation factor for monocytes, macrophages, and someExpand
  • 70
  • 6
Cytoskeletal regulation of Caco‐2 intestinal monolayer paracellular permeability
An abnormal increase in intestinal paracellular permeability may be an important pathogenic factor in various intestinal diseases. The intracellular factors and processes that regulate and causeExpand
  • 55
  • 1
Using REMBRANDT to Paint in the Details of Glioma Biology: Applications for Future Immunotherapy
Microarray technology developed in the late 1990’s allows one to simultaneously analyze the entire transcriptome of a given population of cells at a single time. It is essentially a microchip withExpand
  • 7
  • 1
  • PDF
NSAID-induced injury of gastric epithelial cells is reversible. Roles of mitochondria, AMP kinase, NGF and PGE2.
BACKGROUND & AIMS Non-steroidal anti-inflammatory drugs (NSAIDs) such as diclofenac (DFN) and indomethacin (INDO) are extensively used worldwide. Their main side effects are injury ofExpand
Mechanisms by which membrane and nuclear ER alpha inhibit adipogenesis in cells isolated from female mice.
Mesenchymal stem cells can differentiate into mature chondrocytes, osteoblasts, and adipocytes. Excessive and dysfunctional visceral adipocytes increase upon menopause and importantly contribute toExpand
Abstract A19: Lung cancers taken from autopsies express more tumor antigens than those taken from surgical resections: Implications for immunoprevention
Lung cancers are fatal cancers, even if caught early, since some cancer cells have spread by the time they are detected. Some lung cancer patients treated by immunotherapy have improved theirExpand
Abstract 2898: HCA519/TPX2: a potential T-cell tumor-associated antigen for human hepatocellular carcinoma
Immunotherapy for human hepatocellular cancer (HCC) is slowly making progress towards treating these fatal cancers. The identification of new antigens can improve this approach. We describe aExpand